Tuttle Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Tuttle Capital Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-705	Closed	-$311K	–	252
2020 Q3	$311K	Buy	705 +8	+1%	+$3.31K	0.21%	95
2020 Q2	$253K	Buy	+697	New	+$234K	0.18%	110
2019 Q2	–	Sell	-10,565	Closed	-$2.89M	–	185
2019 Q1	$2.89M	Buy	+10,565	New	+$2.63M	0.58%	50
2018 Q4	–	Sell	-20,100	Closed	-$4.9M	–	148
2018 Q3	$4.9M	Buy	20,100 +18,020	+866%	+$4.15M	0.93%	29
2018 Q2	$430K	Buy	+2,080	New	+$442K	0.29%	75

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Tuttle Capital Management's TMO Position: Q4 2020 in Review

Tuttle Capital Management sold out of Thermo Fisher Scientific (TMO) in Q4 2020, closing a stake of 705 shares — an estimated $311K sold.

Tuttle Capital Management first reported a position in TMO in Q2 2018 and held it in 5 quarters. The position peaked at $4.9M in Q3 2018. 2,030 funds tracked by Wall St. Rank hold TMO as of Q4 2020.

Tuttle Capital Management reported no remaining Thermo Fisher Scientific position as of Q4 2020 after selling out during the quarter.
Tuttle Capital Management sold 705 Thermo Fisher Scientific shares in Q4 2020, an estimated $311K.
Tuttle Capital Management first reported a position in Thermo Fisher Scientific in Q2 2018 and held it in 5 quarters.
Tuttle Capital Management's Thermo Fisher Scientific position peaked at $4.9M in Q3 2018.
2,030 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2020.

Based on Tuttle Capital Management's 13F filing for Q4 2020, filed 20 Jan 2021.